Cargando…

Faecal Microbiota Dynamics and their Relation to Disease Course in Crohn’s Disease

BACKGROUND: Microbial shifts have been associated with disease activity in Crohn’s disease [CD], but findings on specific taxa are inconsistent. This may be due to differences in applied methods and cross-sectional study designs. We prospectively examined the faecal microbiota in adult CD patients w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Galazzo, Gianluca, Tedjo, Danyta I, Wintjens, Dion S J, Savelkoul, Paul H M, Masclee, Ad A M, Bodelier, Alexander G L, Pierik, Marie J, Jonkers, Daisy M A E, Penders, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764104/ https://www.ncbi.nlm.nih.gov/pubmed/30810207 http://dx.doi.org/10.1093/ecco-jcc/jjz049

Ejemplares similares

The fecal microbiota as a biomarker for disease activity in Crohn’s disease
por: Tedjo, Danyta. I., et al.
Publicado: (2016)

The Effect of Sampling and Storage on the Fecal Microbiota Composition in Healthy and Diseased Subjects
por: Tedjo, Danyta I., et al.
Publicado: (2015)

Fecal Microbial Composition of Ulcerative Colitis and Crohn’s Disease Patients in Remission and Subsequent Exacerbation
por: Wills, Edgar S., et al.
Publicado: (2014)

Impact of Sleeve Gastrectomy on Fecal Microbiota in Individuals with Morbid Obesity
por: Tedjo, Danyta I., et al.
Publicado: (2023)

Histopathological Features in Colonic Biopsies at Diagnosis Predict Long-term Disease Course in Patients with Crohn’s Disease
por: Rezazadeh Ardabili, Ashkan, et al.
Publicado: (2021)

Corticosteroid enhances epithelial barrier function in intestinal organoids derived from patients with Crohn’s disease
por: Xu, Pan, et al.
Publicado: (2021)

Disease Activity Patterns of Crohn’s Disease in the First Ten Years After Diagnosis in the Population-based IBD South Limburg Cohort
por: Wintjens, Dion, et al.
Publicado: (2020)

Modulation of Intestinal Epithelial Permeability by Plasma from Patients with Crohn’s Disease in a Three-dimensional Cell Culture Model
por: Xu, Pan, et al.
Publicado: (2019)

Higher Prevalence of Bacteroides fragilis in Crohn’s Disease Exacerbations and Strain-Dependent Increase of Epithelial Resistance
por: Becker, Heike E. F., et al.
Publicado: (2021)

Metagenomic Profiling of Fecal-Derived Bacterial Membrane Vesicles in Crohn’s Disease Patients
por: Kameli, Nader, et al.
Publicado: (2021)

High Percentage of IBD Patients with Indefinite Fecal Calprotectin Levels: Additional Value of a Combination Score
por: Bodelier, Alexander G. L., et al.
Publicado: (2016)

The reproducibility of skeletal muscle signal intensity on routine magnetic resonance imaging in Crohn's disease
por: Spooren, Corinne E.G.M., et al.
Publicado: (2020)

Inter-kingdom relationships in Crohn’s disease explored using a multi-omics approach
por: Frau, Alessandra, et al.
Publicado: (2021)

Prediction of Inflammatory Bowel Disease Course Based on Fecal Scent
por: Bosch, Sofie, et al.
Publicado: (2022)

Efficacy of faecal microbiota transplantation in Crohn’s disease: a new target treatment?
por: Xiang, Liyuan, et al.
Publicado: (2020)

Control Crohn Safe with episodic adalimumab monotherapy as first-line treatment study (CoCroS): study protocol for a randomised controlled trial
por: Janssen, Laura, et al.
Publicado: (2021)

Current evidence and clinical relevance of drug-microbiota interactions in inflammatory bowel disease
por: Becker, Heike E. F., et al.
Publicado: (2023)

Anaplastic Large Cell T Cell Lymphoma in a Patient With Severe Therapy-refractory Crohn’s Disease on Long-standing Immunosuppressive Medication During Ustekinumab Treatment: A Case Report and Review of the Literature
por: Smeets, Fabiënne G M, et al.
Publicado: (2019)

Mucosal microbial load in Crohn's disease: A potential predictor of response to faecal microbiota transplantation
por: Sarrabayrouse, Guillaume, et al.
Publicado: (2020)

The ileal fungal microbiota is altered in Crohn's disease and is associated with the disease course
por: Olaisen, Maya, et al.
Publicado: (2022)

Systematic Review: Contribution of the Gut Microbiome to the Volatile Metabolic Fingerprint of Colorectal Neoplasia
por: van Vorstenbosch, Robert, et al.
Publicado: (2022)

Does Day-to-Day Variability in Stool Consistency Link to the Fecal Microbiota Composition?
por: Vork, Lisa, et al.
Publicado: (2021)

Development and Validation of a Remote Monitoring Tool for Assessment of Mild, Moderate, and Severe Infections in Inflammatory Bowel Disease
por: Rezazadeh Ardabili, Ashkan, et al.
Publicado: (2023)

Fecal microbiota composition is linked to the postoperative disease course in patients with Crohn’s disease
por: Strömbeck, Anna, et al.
Publicado: (2020)

The Impact of Pectin Supplementation on Intestinal Barrier Function in Healthy Young Adults and Healthy Elderly
por: Wilms, Ellen, et al.
Publicado: (2019)

Association of gut microbiota with post-operative clinical course in Crohn’s disease
por: Dey, Neelendu, et al.
Publicado: (2013)

Modulation of faecal metagenome in Crohn’s disease: Role of microRNAs as biomarkers
por: Rojas-Feria, María, et al.
Publicado: (2018)

A pilot study of the use of the oral and faecal microbiota for the diagnosis of ulcerative colitis and Crohn's disease in a paediatric population
por: Monleón-Getino, A., et al.
Publicado: (2023)

Association between Parkinson’s disease and the faecal eukaryotic microbiota
por: Weis, Severin, et al.
Publicado: (2021)

Faecal Microbiota Transplantation and Chronic Kidney Disease
por: Bian, Ji, et al.
Publicado: (2022)

Intestinal permeability in human nonalcoholic fatty liver disease: A systematic review and meta‐analysis
por: De Munck, Toon J. I., et al.
Publicado: (2020)

In vitro metabolic capacity of carbohydrate degradation by intestinal microbiota of adults and pre-frail elderly
por: An, Ran, et al.
Publicado: (2021)

Gut Microbiota and Parkinson’s Disease: Implications for Faecal Microbiota Transplantation Therapy
por: Kang, Yongbo, et al.
Publicado: (2021)

Severe COVID-19 in inflammatory bowel disease patients in a population-based setting
por: Creemers, Rob H., et al.
Publicado: (2021)

Faecal calprotectin and magnetic resonance imaging in detecting Crohn’s disease endoscopic postoperative recurrence
por: Baillet, Pierre, et al.
Publicado: (2018)

The effect of olive leaf extract on cardiovascular health markers: a randomized placebo-controlled clinical trial
por: Stevens, Yala, et al.
Publicado: (2020)

The Utility of Faecal Calprotectin, Lactoferrin and Other Faecal Biomarkers in Discriminating Endoscopic Activity in Crohn’s Disease: A Systematic Review and Meta-Analysis
por: Bohra, Anuj, et al.
Publicado: (2023)

Impact of early events and lifestyle on the gut microbiota and metabolic phenotypes in young school-age children
por: Zhong, Huanzi, et al.
Publicado: (2019)

The role of faecal microbiota transplantation in the treatment of inflammatory bowel disease
por: Haifer, Craig, et al.
Publicado: (2020)

Dysbiotic microbiota interactions in Crohn’s disease
por: Caparrós, Esther, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jdg2qi7je5ctctmpef8d9rri4c